Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine in Geriatric Hip Fractures
NCT03289858Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Sep 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine extended release liposome injection in Hip fracture, sponsored by University of Massachusetts. Started Sep 2017; status: completed.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
Hip fracture
Beyond the preview
Go deeper on NCT03289858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289858.